drugset / Trial / NCT04185441

Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

NCT04185441

Phase 3 Completed 295 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Tanzânia association in adults with erectile dysfunction associated with Benign Prostatic Hyperplasia.

Timeline

Start
2021-03-14
Primary completion
2023-10-10
Completion
2024-07-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tamsulosin Other / unclassified 0.4 mg Oral
Subject Tanzânia association Unknown Oral